Print Page     Close Window     

SEC Filings

424B3
BIOTIME INC filed this Form 424B3 on 02/04/2019
Entire Document
 

 

 

Your vote is important. Whether or not you expect to attend in person, we urge you to vote your shares as promptly as possible by:

 

(1) accessing the Internet website specified on your proxy card;

 

(2) calling the toll-free number specified on your proxy card; or

 

(3) marking, signing, dating and returning the enclosed proxy card in the postage-paid envelope provided,

 

so that your shares may be represented and voted at the BioTime Special Meeting. If your shares are held in the name of a broker, bank, trust company or other nominee, please follow the instructions on the voting instruction card furnished by the record holder.

 

Please note that if you hold shares in different accounts, it is important that you vote the shares represented by each account.

 

The enclosed joint proxy statement/prospectus provides a detailed description of the Merger and the Merger Agreement. We urge you to read this joint proxy statement/prospectus, including any documents incorporated by reference, and the annexes carefully and in their entirety. If you have any questions concerning the Merger or this joint proxy statement/prospectus, would like additional copies or need help voting your BioTime Common Shares, please contact BioTime:

 

BioTime, Inc.

1010 Atlantic Avenue, Suite 102

Alameda, California 94501

Attention: Investor Relations

Telephone: (510) 871-4188

 

By Order of the Board of Directors,

Brian M. Culley

Chief Executive Officer

 

   

© Copyright BioTime, Inc.